Managed Care and Health System Collaboration To Deliver Value and Equitable Access to Gene and Cell Therapy for Rare Diseases
Pricing: Free for Members and Non-Members
This activity is supported by an independent medical education grant from Pfizer Inc.
Course Description
Gene and gene-modified cell therapy innovations are evolving, and novel treatment approaches for genetically inherited diseases are emerging to meet medical needs for rare diseases. Approximately 7,000 identified rare diseases exist, yet only a few hundred treatments are approved. Gene and cell therapy is particularly relevant to patients with a rare disease, as more than 80 percent of rare diseases have a known single-gene cause.
Faculty for this session will provide an overview of gene and cell therapy innovation for rare diseases, details of the new and pipeline clinical indications, and host a discussion between managed care and health systems on collaborating strategies to bridge access and utilization of these therapies.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to
- Review the incidence, current treatment options, and pipeline for hemophilia, a rare blood disorder.
- Identify managed care considerations for developing payment models for hemophilia.
- Discuss innovative methods to address access to care for the rare blood disease hemophilia and emerging durable cure treatments
Faculty
Andreas Klein, MD
Director, Transplant and Cellular Therapy Program
Tufts Medical Center
Kasey Raetz, PharmD
VP, Pharma Contracting & Strategy
Express Scripts
Moderator
Alex Dong, PharmD
Senior Manager, Specialty Product Development - Gene Therapy
CVS Health
Financial Relationship Disclosures
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Kasey Raetz, PharmD Faculty | Disclosed no relevant financial relationships. |
Andreas Klein, MC Faculty | DSMB Chair: Pfizer, Inc. DSMB Member: LOXO@Lilly, Takeda |
Marshall Summar, MD | Disclosed no relevant financial relationships. |
Elizabeth Saltzman, PharmD Reviewer | Disclosed no relevant financial relationships. |
Jennifer Evans Planner | Disclosed no relevant financial relationships. |
Ryan Shan Planner | Disclosed no relevant financial relationships. |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-23-039-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1
Release Date: August 29, 2023 • Expiration Date: December 31, 2024
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at eLearning Day 2023. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.00 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.00 Certificate of Completion
Price
Required Hardware/software
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities